M NE 17 (Nisoldipine extended release 17 mg)

Pill imprint M NE 17 has been identified as Nisoldipine extended release 17 mg.

Nisoldipine is used in the treatment of raynaud's syndrome; high blood pressure; angina pectoris prophylaxis and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nisoldipine 17 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nisoldipine extended release

Imprint:

M NE 17

Strength:

17 mg

Color:

Yellow

Shape:

Round

Availability:

Prescription only

Drug Class:

Calcium channel blocking agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-2097

Inactive Ingredients:

silicon dioxide
hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Yellow No. 6
polydextrose
polyethylene glycol
titanium dioxide
triacetin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.